CVS Health (CVS) Income Statement Flow — TTM through Q1 2026
Calculated from the four most recent reported quarters, ending (reported ).
CVS Health (CVS) Revenue by Product Segment — TTM through Q1 2026
Aggregated from the four quarterly disclosures behind this TTM. Minor differences vs the company's annual filing can occur if reported segments changed mid-year.
| Segment | Revenue (USD) | % of total |
|---|---|---|
| Pharmacy Revenue | $239B | 58.5% |
| Premiums | $139B | 34% |
| Front Store Revenue | $21.9B | 5.4% |
| Product and Service, Other | $8.58B | 2.1% |
| Corporate And Other Segment | $227M | 0.1% |
| Total | $408B | 100% |
- Pharmacy Revenue$239B
- Premiums$139B
- Front Store Revenue$21.9B
- Product and Service, Other$8.58B
- Corporate And Other Segment$227M
- Total$408B
Revenue Breakdown — TTM through Q1 2026
In TTM through Q1 2026, CVS Health (CVS) reports revenue across 5 reportable product segments; the largest segment was Pharmacy Revenue at 58.5%, followed by Premiums (34%) and Front Store Revenue (5.4%).
Frequently asked questions
Data & methodology
CVS Health (CVS) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks
- Dividend Profile2.51% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History4 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.